.Pharmacolibrary.Drugs.C_CardiovascularSystem.C03E_DiureticsAndPotassiumSparingAgentsInCombination.C03EA05_MebutizideAndPotassiumSp.MebutizideAndPotassiumSp .Pharmacolibrary.Drugs.C_CardiovascularSystem.C03E_DiureticsAndPotassiumSparingAgentsInCombination.C03EA05_MebutizideAndPotassiumSp.MebutizideAndPotassiumSp| name: | MebutizideAndPotassiumSparingAgents | |
| ATC code: | C03EA05 | route: | oral |
| compartments: | 1 | |
| dosage: | 10 | mg |
| volume of distribution: | 30 | L |
| clearance: | 1.5 | L/h |
| other parameters in model implementation | ||
Mebutizide is a thiazide-like diuretic used in the treatment of hypertension and edema. The fixed combination with potassium-sparing agents is used to reduce potassium loss associated with thiazide diuretics. This drug combination is not widely used today and is not approved in many countries.
No published pharmacokinetic studies are available for the fixed combination of mebutizide and potassium-sparing agents in any population.